Bipolar Disorder (2018) |
1.27 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LYG1 |
Bipolar Disorder or Schizophrenia |
1.48 |
15 |
5 |
11.1 |
-0.48 |
6.3e-02 |
ABCB9 C12orf65 EDEM2 GNL3LP1 HSD11B2 LOC440957 PCNX PROCR REEP2 RP11-182J1.14 SETD8 TMEM110 ZCCHC8 ZMYM4 ZNF354C |
Depressed Affect (Nagel 2018) |
1.63 |
9 |
7 |
15.6 |
0.72 |
8.6e-03 |
ATAD2B LRRC37A LRRC37A2 LRRC37A4P MAPT NICN1 NICN1-AS1 RHOA WNT3 |
Depression (Nagel 2018) |
1.08 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A2 |
Intelligence (Savage-Jansen 2018) |
1.34 |
17 |
12 |
26.7 |
-0.48 |
3.2e-02 |
ABCB9 ALKBH5 AMT CENPW DISP2 HERC1 JUND LOC440957 LRRC37A2 MAPT MGAT3 NICN1 NICN1-AS1 RBL2 RHOA SETD8 ZMAT2 |
Neuroticism (Nagel 2018) |
1.64 |
9 |
6 |
13.3 |
0.97 |
3.8e-07 |
ADM ATAD2B CENPW LRRC37A LRRC37A2 LRRC37A4P MAPT MGC57346 WNT3 |
Schizophrenia (2018) |
1.51 |
8 |
4 |
8.9 |
-0.83 |
1.1e-02 |
ABCB9 ABHD5 C12orf65 PCNX RP11-182J1.14 SETD8 ZCCHC8 ZMYM4 |
Schizophrenia vs Biploar Disorder |
1.40 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LYG1 |
Worry (Nagel 2018) |
1.32 |
11 |
8 |
17.8 |
0.96 |
2.0e-08 |
CENPW LOC440957 LRRC37A LRRC37A2 LRRC37A4P MAPT PAM SEMA3B-AS1 TIMP4 TKT WNT3 |
Crohns Disease (2017) |
1.13 |
5 |
3 |
6.7 |
0.48 |
3.3e-01 |
NICN1 NICN1-AS1 RP11-400F19.6 RSPO3 ZFP36L2 |
Irritable Bowel Disease (IBD) |
1.22 |
10 |
5 |
11.1 |
0.42 |
2.2e-01 |
AMT HSD17B1P1 NICN1 NICN1-AS1 PRKAR2A RHOA RP11-400F19.6 RP11-548H3.1 TOM1 ZFP36L2 |
Ulcerative Colitis (UC) |
1.23 |
8 |
5 |
11.1 |
0.27 |
5.1e-01 |
AMT HSD17B1P1 NICN1 NICN1-AS1 PRKAR2A RGS19 RHOA TOM1 |
Reaction Time |
1.25 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CCDC92 KANSL1 LRRC37A |
Verbal and Numeric Reasoning (VNR) |
1.33 |
8 |
4 |
8.9 |
-0.76 |
1.8e-02 |
ALKBH5 DISP2 DPY30 JUND LOC440957 MGAT3 NICN1 RBL2 |
Breast Cancer |
1.84 |
17 |
10 |
22.2 |
0.32 |
1.6e-01 |
AP006621.6 CHEK2 CPEB4 CTC-425F1.4 CTD-2310F14.1 DNPH1 HSPA4 L3MBTL3 LRRC37A LRRC37A2 LRRC37A4P MAPT PPP2R1B RP11-250B2.5 RP11-554A11.9 TCF7L2 WNT3 |
Ovarian Cancer |
1.53 |
5 |
5 |
11.1 |
-0.99 |
9.8e-07 |
LRRC37A LRRC37A2 LRRC37A4P MAPT WNT3 |
Prostate Cancer |
1.65 |
1 |
1 |
2.2 |
0.80 |
1.0e-01 |
RP11-554A11.9 |
Age at First Birth |
1.10 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NICN1 |
Coronary Artery Disease (CAD) |
1.56 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-380L11.3 |
Crohns Disease (2012) |
1.16 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
NICN1 ZFP36L2 |
Fasting Glucose |
1.20 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ABHD1 |
HbA1C |
1.20 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM1A |
HDL Cholesterol |
1.88 |
11 |
7 |
15.6 |
-0.56 |
7.3e-02 |
ABCA1 C6orf106 CCDC92 DNAH10 GPR109B GRB14 LOC440957 MLXIPL PTPRJ RP11-380L11.3 RSPO3 |
LDL Cholesterol |
1.43 |
5 |
2 |
4.4 |
0.97 |
3.0e-04 |
ABCA1 FUT2 MKRN2 PRO0628 SLC22A3 |
Neuroticism (2016) |
1.22 |
5 |
2 |
4.4 |
0.99 |
2.4e-04 |
ADM LRRC37A LRRC37A2 LRRC37A4P MAPT |
Primary Biliary Cirrhosis |
1.48 |
4 |
1 |
2.2 |
-0.64 |
3.6e-01 |
CCDC88B LRRC37A LRRC37A4P SLC26A1 |
Schizophrenia (2014) |
1.50 |
9 |
5 |
11.1 |
-0.45 |
1.9e-01 |
ABCB9 C12orf65 GNL3LP1 LOC440957 PCNX REEP2 RP11-182J1.14 SETD8 ZCCHC8 |
Triglycerides |
2.03 |
7 |
3 |
6.7 |
0.66 |
1.1e-01 |
ABHD1 CCDC92 DNAH10 GRB14 MLXIPL RP11-380L11.3 SLC22A3 |
Type 2 Diabetes (T2D) (2012) |
1.89 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
EIF2S2P3 JAZF1 TCF7L2 |
Ulcerative Colitis |
1.21 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
NICN1 NICN1-AS1 |
Blood Eosinophil Count |
1.46 |
50 |
36 |
80.0 |
-0.04 |
7.9e-01 |
ADAM1A AMT AUH BANF1 CALCRL CAND2 CCDC157 CCDC88B CPEB4 DMWD EBPL EIF2S2P3 FGFR4 FLJ33630 HNRNPA1 HSD11B2 HSD17B1P1 IFI35 IQCH JAZF1 KAT5 KCNJ2 LRRC37A LRRC37A2 LRRC37A4P LUZP1 MAPT MGC57346 MKRN2 NICN1 NMRAL1 P4HTM PACS1 PGC PRKAR2A PTPRJ RNF185 RP1-130H16.16 RP11-876N24.5 RSBN1L SETD8 SLC7A6 TCEA3 TIMP4 TMEM110 TRIM8 WNT3 ZCCHC8 ZFP36L2 ZNF652 |
Blood Platelet Count |
1.33 |
67 |
52 |
115.6 |
0.21 |
5.0e-02 |
ABCB9 ADAM1A AKIP1 AL132989.1 BCL2L11 C10orf11 C12orf65 C4orf44 C6orf106 CAND2 CBY1 CCDC157 CCDC92 CDC42EP3 CEBPA CRIP3 DMWD DYM E2F3 ENDOG ETAA1 FLJ12825 FUT2 GLS GPR109A HNRNPA1 IPPK ITGA9 KANSL1 KAT5 KCNJ11 KIAA1875 LIPE LOC440957 LPAL2 LRRC37A LRRC37A4P MAF1 MGC57346 MLXIPL MTFP1 NMRAL1 ORAOV1 OTUD4 PAM16 PGC PRDX5 RP1-130H16.16 RP11-548H3.1 RP11-95P2.1 RSPO3 SEMA3B-AS1 SETD8 SLC7A6 SNUPN THOC5 TIMP4 TMEM241 TNFSF12 TOM1 TPCN1 TRIM8 WIT1 WNT3 ZCCHC8 ZFP36L2 ZZEF1 |
Blood Red Count |
1.98 |
69 |
48 |
106.7 |
0.31 |
4.5e-03 |
ABCB9 ADAM1A ADM AKIP1 AL132989.1 ALKBH5 C10orf11 C17orf82 CCDC144B CCDC88B CCDC92 CD79B CEBPA CENPW CEP89 CLOCK COBLL1 CPEB4 CRYAB CTC-425F1.4 CTD-2085J24.4 DNAH10 DNASE1L3 DNMT3A DNPH1 DOT1L ELL FGFR4 GRB14 HNRNPA1 HSD11B2 KANSL1 KBTBD2 KCNAB3 L3MBTL3 LOC440957 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MGC57346 MKRN2 MLXIP NICN1-AS1 PCK1 PPP2R1B PPP6R3 PRIM1 RAD9A RHOA RIC8B RP11-108M9.5 RP11-380L11.3 RP11-57H14.2 RP1-261G23.7 RSPO3 SEMA3B-AS1 SETD8 SLC7A6 SPSB1 SRD5A3 TCEA3 TMEM110 TMEM165 VEGFB WNT3 ZCCHC8 ZNF503-AS2 |
Blood White Count |
1.27 |
50 |
36 |
80.0 |
0.55 |
5.1e-06 |
ADAM1A ADORA2B ALKBH5 AUH BANF1 BCAR3 BHLHE41 C4orf44 C6orf106 CALCRL CAND2 CASKIN1 CCDC92 CENPW EBPL EPC1 FFAR4 FLJ12825 FLJ33630 HOXC6 IPPK L3MBTL3 LIPE LPAR1 LRRC37A LRRC37A4P MLXIPL NBEAL2 NDST1 NICN1 NMRAL1 ORAOV1 PAM PGS1 PLA2G4B PRDX5 PTPRJ RASD1 RFT1 RIC8B RNF185 RP11-283G6.5 RP11-380L11.3 RP11-400F19.6 RP11-876N24.5 SNUPN SSPN TNFAIP8 TRIM8 VEGFB |
Heel T-Score |
3.33 |
103 |
81 |
180.0 |
0.17 |
6.0e-02 |
ABCB9 AKIP1 AL132989.1 AMT ANAPC10 BHLHE41 CALCRL CASKIN1 CBY1 CCDC157 CCDC53 CCDC88B CCDC92 CEBPA CMSS1 CPEB4 CRIP3 CTBP1 CTD-2310F14.1 CYBRD1 DEPTOR DGKQ DMWD DNAH10 DOT1L EBPL EDEM2 EEF1G ETAA1 EYA2 FGFR4 FLJ33630 GPATCH1 HINT3 HNRNPA1 HOTAIR HOXC11 HOXC6 HSD11B2 HSD17B1P1 HSPA4 IFI35 IPPK IQCH KAT5 L3MBTL3 LACTB2 LITAF LOC440957 LRRC37A LRRC37A2 LRRC37A4P LRRC45 LYG1 LYSMD4 MAEA MAPT MEIS1 MKRN2 MKX MMP16 MRPS35 MTFP1 MTOR NBEAL2 NMRAL1 P4HTM PAM16 PIH1D2 PPP6R3 PRKAR2A PROCR PSMB3 PTPRJ RAB24 RASD1 RHOA RP11-283G6.5 RP1-130H16.16 RP11-380L11.3 RP11-400F19.6 RP11-554A11.9 RP11-57H14.2 RP11-95P2.1 RSPO3 SERTAD3 SETD8 SLC18B1 SPSB1 SSPN STK38L TCEA3 THOC5 TIGD7 TRAM1 TTC39A VGLL4 WNT3 WNT4 XKR9 ZCCHC8 ZFP36L2 ZNRF3 |
BMI |
1.42 |
54 |
33 |
73.3 |
-0.74 |
2.2e-11 |
ADORA2B AP006621.6 AP3B1 C12orf65 C17orf82 C6orf106 CCDC92 COBLL1 CPEB4 CYBRD1 CYTL1 DNAH10 GRB14 HOXA9 IQCH JAZF1 JUND KANSL1 KBTBD2 KCNJ11 L3MBTL3 LOC440957 MLXIP MLXIPL MMP16 MTOR NICN1 NLRC3 ORAOV1 OTUD4 PAM POMC PPP6R3 PRDX5 PURA RAB24 RHOA RP11-380L11.3 RP11-400F19.6 RPS6KA5 RSBN1L RSRC2 SEMA3B-AS1 SLC22A3 TCEA3 TCF7L2 TMEM110 TMEM241 TRIM8 YBX2 YTHDC2 ZCCHC24 ZCCHC8 ZMAT2 |
Height |
3.67 |
160 |
145 |
322.2 |
-0.11 |
1.3e-01 |
ABCB9 ACTR3 ADAM17 ADCY3 ADM AKR1C2 AKR1E2 ALKBH5 AMT ANAPC10 AP3B1 ATAD2B ATP6V0A2 BANF1 C10orf11 C17orf82 C4orf44 C6orf106 C9orf5 CAND2 CASKIN1 CCDC144B CCDC53 CCDC92 CD79B CENPW CEP250 CLOCK CMSS1 COL15A1 COL6A2 CRIP3 CTBP1 CTC-425F1.4 CTD-2310F14.1 CYBRD1 CYTL1 DISP2 DMWD DNMT3A DOT1L DPY30 DSCR10 DYM EBPL EDEM2 ELOVL4 EYA1 FGF11 FGFR4 FLJ33630 FUT2 GDF5 GLS GPX8 H1FX HINT3 HSD11B2 HSD17B1P1 IGF1R IGFBP3 IPO8 JAZF1 KANSL1 KCNAB3 KCNJ11 KCNJ2 KIAA1875 L3MBTL3 LIPE LOC440957 LPAL2 LPAR1 LRRC37A LRRC37A2 LRRC37A4P LRRC45 LUZP1 LYSMD4 MAEA MAF1 MAPT MGAT3 MGC57346 MKRN2 MKX MLXIP MLXIPL MRPS35 MTOR MXD3 NBEAL2 NICN1 NUDT6 OTUD4 P4HTM PAM PGC PLXND1 POLD3 POMC PPP2R1B PPP6R3 PQLC3 PRIM1 PRKAR2A PROCR PSMB3 PTPRJ PURA RAB24 RAD9A RBL2 RFT1 RHOA RIC8B RNASEH2B RP11-108M9.5 RP11-10C24.2 RP11-182J1.14 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RP11-283G6.5 RP11-548H3.1 RP11-554A11.9 RP11-95P2.1 RRAS2 RSBN1L RSRC2 SEMA3B-AS1 SETD8 SLC16A11 SLC22A3 SLC25A19 SNRPD2 SNUPN SPSB1 SRD5A3 SSPN STOML1 TBX10 TMEM110 TMEM165 TMEM241 TOM1 TRIM8 TTC39A UQCC UQCC1 USP53 WDR5 WDR92 WNT3 WNT4 ZCCHC8 ZFP36L2 ZNF354C ZNHIT6 ZSCAN2 |
Systolic Blood Pressure |
1.84 |
61 |
42 |
93.3 |
0.29 |
2.0e-02 |
AC004540.4 ADAM1A ADCY3 ADM BHLHE41 C17orf82 C22orf31 CEP250 CLOCK CMSS1 CPEB4 CRIP3 CTD-3032J10.3 CYBRD1 DMWD DNMT3A EYA1 FAM13A FGF11 FLJ12825 FLJ33630 FUT2 GLS GRB14 HOXC6 HSPA4 ITGA9 KAT5 KCNJ11 LPAR1 LRRC37A4P MAPT PCNX PDCL2 PGC PLA2G4B PRDX5 PTPRJ RGS19 RP11-548H3.1 RP11-95P2.1 RSBN1L RSRC2 SRD5A3 SRD5A3-AS1 SSPN TCF7L2 THOC5 TMEM165 TNFAIP8 TNFSF12 UQCC UQCC1 VEGFB VGLL4 WDR92 WIT1 WNT3 ZMAT2 ZMYM4 ZNRF3 |
Smoking Status |
1.20 |
10 |
4 |
8.9 |
-0.51 |
1.3e-01 |
ADAM1A AMT C6orf106 IQCH KCNJ11 LRRC37A2 NICN1 P4HTM PPP6C RHOA |
Allergy or Eczema |
1.37 |
15 |
9 |
20.0 |
-0.28 |
3.1e-01 |
ADAM1A BANF1 C6orf106 CALCRL CHEK2 ENDOG IQCH JAZF1 MLXIP PRR5L RP11-400F19.6 RP11-876N24.5 SETD8 TRIM8 ZMYM4 |
Cardiovascular Disease |
1.76 |
27 |
16 |
35.6 |
0.54 |
2.1e-03 |
ADAM1A ADCY3 C17orf82 C22orf31 C4orf44 CALCRL CLOCK CPEB4 CRIP3 CTD-3032J10.3 E2F3 FLJ12825 FUT2 HOXC6 HSPA4 KCNJ11 MLXIPL MXD3 PCNX PLA2G4B PRDX5 RBL2 RGS19 SRD5A3 TMEM165 VEGFB ZNRF3 |
Hypothyroidism (self reported) |
1.48 |
11 |
5 |
11.1 |
-0.08 |
8.0e-01 |
ADAM1A CCDC88B ENDOG FUT2 HSD11B2 JUND KIAA1683 PRDX5 RSBN1L TIMP4 TPCN1 |
Respiratory disease |
1.12 |
4 |
3 |
6.7 |
-0.35 |
6.5e-01 |
DMWD IQCH PRR5L RP11-876N24.5 |
Type 2 Diabetes (T2D) (2018) |
2.57 |
16 |
9 |
20.0 |
0.67 |
3.3e-03 |
CENPW COBLL1 E2F3 EIF2S2P3 EYA2 GRB14 JAZF1 KCNJ11 PAM PLA2G4B RBL2 RP11-400F19.6 SNUPN TCF7L2 ZCCHC24 ZFP36L2 |
Lung FEV1/FVC ratio |
1.79 |
51 |
34 |
75.6 |
0.11 |
4.2e-01 |
ADM ALKBH5 ATP6V0A2 C10orf11 C22orf31 CALCRL CEBPA CENPW CEP250 COL15A1 CPEB4 DMWD EEF1G FAM13A FGFR4 FLJ12825 FLJ33630 FUT2 GDF5 HERC1 HOXC6 HSD11B2 HSPA4 IQCH JUND KIAA1683 LOC100240734 LRRC37A LYG1 LYSMD4 MRPS35 MTOR NID2 NMRAL1 OTUD4 PLA2G4B PSMB3 RASD1 RFT1 RP11-108M9.5 RP11-182J1.14 RP11-95P2.1 RREB1 SLC7A6 TMEM110 VGLL4 XKR9 ZFP36L2 ZNF354C ZSCAN2 ZZEF1 |
Lung FVC |
2.65 |
63 |
44 |
97.8 |
-0.30 |
1.2e-02 |
ABLIM3 ADORA2B ANAPC10 AP3B1 C17orf82 C6orf106 CD79B CENPW CEP250 CMSS1 CYTL1 DISP2 DOT1L EDEM2 EEF1G EML3 EYA2 FGF11 FLJ12825 FLJ33630 GDF5 GPX8 HOXC11 HOXC6 HSPA4 IGF1R IPO8 IPPK IQCH JAZF1 JUND KIAA1683 KIAA1875 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MGC57346 MRPS35 NICN1 NLRC3 NMRAL1 PROCR RGS19 RHOA RP11-108M9.5 RP1-125I3.2 RP11-64K12.8 SEMA3B-AS1 SETD8 SLC16A11 SLC25A19 SNUPN TFG TMEM241 TNFAIP8 TRAM1 UQCC UQCC1 WNT3 WNT4 ZCCHC24 |
Neuroticism |
1.65 |
10 |
5 |
11.1 |
0.89 |
4.1e-05 |
ADM ATAD2B CENPW IQCH LRRC37A LRRC37A2 LRRC37A4P MAPT MGC57346 WNT3 |
Chronotype (morning person) |
1.09 |
4 |
2 |
4.4 |
-0.98 |
1.7e-02 |
ALG10 CTBP1 KBTBD2 SEMA3B-AS1 |
Hair Pigment |
0.82 |
35 |
24 |
53.3 |
0.07 |
6.3e-01 |
ADM BHLHE41 C22orf31 CCDC144B CDC42EP3 CEP250 E2F3 EDEM2 EML3 FKBP10 GDF5 JAZF1 KANSL1 KAT5 L3MBTL3 LRRC37A LRRC45 MKRN2 MYEOV NMRAL1 PCNX PROCR RGS19 RP11-283G6.5 RP11-554A11.9 SETD8 SLC25A19 TET2 TOM1 UQCC UQCC1 WNT3 ZCCHC24 ZFP36L2 ZNRF3 |
Tanning |
1.11 |
13 |
10 |
22.2 |
-0.35 |
1.5e-01 |
CEP250 EDEM2 GDF5 JAZF1 LOC440957 MXD3 PGC POMC PROCR RP11-554A11.9 RP11-64K12.8 UQCC UQCC1 |
Hand grip strength (left) |
1.99 |
23 |
21 |
46.7 |
-0.62 |
7.0e-04 |
CASKIN1 CCDC53 CCDC92 CD79B CEP250 DOT1L DYM EDEM2 GDF5 L3MBTL3 LRRC37A LRRC37A2 LRRC37A4P LUZP1 MAPT MMP16 POLD3 PSMB3 RAD9A RP11-250B2.6 UQCC UQCC1 WNT3 |
Sensitivity / hurt feelings |
1.67 |
6 |
5 |
11.1 |
0.97 |
1.5e-05 |
LRRC37A LRRC37A2 LRRC37A4P MAPT MGC57346 WNT3 |
Frequency of depressed mood in last 2 weeks |
1.08 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A2 |
Hearing difficulty/problems: Yes |
1.20 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
C4orf44 CRIP3 |
Relative age of first facial hair |
2.09 |
9 |
6 |
13.3 |
0.69 |
9.8e-03 |
ETAA1 HSPA4 LIPE LRRC37A LRRC37A2 LRRC37A4P MAPT VGLL4 WNT3 |
Ever used hormone-replacement therapy (HRT) |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PEPD |
Systolic blood pressure, automated reading |
1.42 |
19 |
5 |
11.1 |
-0.35 |
1.4e-01 |
C17orf82 C22orf31 CPEB4 DEPTOR FGF11 ITGA9 KCNJ11 LRRC37A LRRC37A4P MAPT PDCL2 PLA2G4B RGS19 SRD5A3-AS1 TNFSF12 VGLL4 WNT3 YBX2 ZNRF3 |
Eye problems/disorders: Diabetes related eye disease |
1.32 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TCF7L2 |
Angina |
1.04 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A3 |
Vitamin and mineral supplements |
1.31 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NBEAL2 |
Medication: Metformin |
2.05 |
6 |
3 |
6.7 |
0.97 |
1.6e-03 |
EIF2S2P3 JAZF1 KCNJ11 RP11-400F19.6 TCF7L2 ZCCHC24 |
Diabetes (father) |
1.67 |
4 |
2 |
4.4 |
0.79 |
2.1e-01 |
E2F3 EIF2S2P3 TCF7L2 ZFP36L2 |
Diabetes (mother) |
1.84 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
EIF2S2P3 SSPN TCF7L2 |
Pack years adult smoking proportion |
1.10 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
AMT PRKAR2A |
Impedance of leg (right) |
2.53 |
69 |
54 |
120.0 |
0.86 |
7.4e-23 |
ADM ADORA2B ALKBH5 AP006621.6 AP3B1 C10orf11 C6orf106 CD79B CEP250 CTD-3032J10.3 CYBRD1 DNASE1L3 DSCR10 EBPL EDEM2 FANCL FGFR4 FLJ12825 FLJ33630 GDF5 GNL3LP1 HINT3 HOXC6 HSD11B2 IGFBP3 IPPK JAZF1 JUND KCNJ11 KIAA1683 KIAA1875 L3MBTL3 LOC440957 LRRC37A4P MLXIPL MMP16 MTOR MXD3 MYEOV NLRC3 NUDT6 ORAOV1 OTUD4 PAM PDE4C PGC PLA2G4B POMC PPP6R3 PRIM1 PURA RAB24 RAD9A RASD1 RBL2 RBPJ RP11-108M9.5 RP11-182J1.14 RPS6KA5 SEMA3B-AS1 SPSB1 TMEM110 TRIM8 UQCC UQCC1 USP53 WNT4 ZFP36L2 ZSCAN2 |
Leg fat-free mass (left) |
2.82 |
68 |
58 |
128.9 |
-0.70 |
6.8e-12 |
ADM ADORA2B AKR1C2 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CPEB4 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FLJ33630 GDF5 GPX8 H1FX IGFBP3 IPPK KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAD9A RBL2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Trunk fat percentage |
2.22 |
54 |
36 |
80.0 |
-0.47 |
9.1e-05 |
ABHD1 ADAMTS9-AS2 ADM AP3B1 C12orf65 C6orf106 CASKIN1 CCDC92 CENPW CLOCK COBLL1 DNAH10 EEF1G ETAA1 EYA2 FAM13A FGF11 FLJ12825 GRB14 HOXA9 HOXC6 IDUA IL12RB1 IQCH JUND KIAA1683 LRRC37A LRRC37A2 LRRC37A4P MAPT MLXIP OTUD4 PDCL2 PDE4C PRDX5 PURA RAD9A RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RRAS2 RSBN1L RSRC2 SLC22A3 SLC26A1 SLC38A11 SRD5A3 TBX10 TMEM165 TMEM241 TNFSF12 WNT3 YBX2 ZSCAN2 |
Hand grip strength (right) |
2.14 |
24 |
19 |
42.2 |
-0.60 |
9.2e-04 |
CASKIN1 CCDC53 CCDC92 CD79B CEP250 CYBRD1 DOT1L DYM EDEM2 GDF5 L3MBTL3 LRRC37A LRRC37A2 LRRC37A4P LUZP1 MAPT POLD3 PROCR PSMB3 RAD9A RP11-250B2.6 UQCC UQCC1 WNT3 |
Current tobacco smoking |
1.14 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPP6C |
Fed-up feelings |
1.54 |
10 |
6 |
13.3 |
0.64 |
1.8e-02 |
ATAD2B LRRC37A LRRC37A2 LRRC37A4P MAPT NICN1 NICN1-AS1 PRDX5 RHOA WNT3 |
Relative age voice broke |
1.74 |
8 |
5 |
11.1 |
0.85 |
4.1e-04 |
AKR1C2 LRRC37A LRRC37A2 LRRC37A4P MAPT RP11-95P2.1 UQCC WNT3 |
Age when periods started (menarche) |
1.40 |
10 |
9 |
20.0 |
-0.50 |
9.9e-02 |
C9orf5 CENPW LOC440957 NICN1 NICN1-AS1 PGC PPP6C RFT1 RHOA TMEM110 |
Bilateral oophorectomy (both ovaries removed) |
1.14 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
WNT4 |
Heel bone mineral density (BMD) T-score, automated (left) |
2.18 |
12 |
10 |
22.2 |
0.39 |
1.7e-01 |
CCDC92 EBPL KAT5 LACTB2 PPP6R3 PROCR RP11-380L11.3 RSPO3 TRAM1 WNT4 XKR9 ZNRF3 |
High blood pressure |
1.62 |
22 |
10 |
22.2 |
0.41 |
5.7e-02 |
AC004540.4 ADAM1A ADCY3 C22orf31 CRIP3 CTD-3032J10.3 E2F3 FGF11 FGF9 FLJ12825 HOXC6 KCNJ11 MAPT PLA2G4B PTPRJ RBL2 RGS19 RSRC2 THOC5 TNFSF12 VEGFB ZNRF3 |
Hayfever, allergic rhinitis or eczema |
1.31 |
7 |
3 |
6.7 |
-0.48 |
2.8e-01 |
ADAM1A BANF1 ENDOG RP11-400F19.6 RP11-876N24.5 SETD8 TRIM8 |
Medication: Levothyroxine sodium |
1.31 |
4 |
2 |
4.4 |
0.49 |
5.1e-01 |
ADAM1A CCDC88B HSD11B2 TIMP4 |
Sitting height |
3.95 |
92 |
78 |
173.3 |
-0.53 |
4.0e-09 |
ABCB9 ADM AKR1C2 AMT ANAPC10 ANXA5 AP3B1 C10orf11 C12orf65 C6orf106 CALCRL CASKIN1 CCDC53 CD79B CENPW CEP250 CLOCK CRIP3 CYBRD1 DMWD DNMT3A DOT1L DPY30 DYM EBPL EDEM2 ELOVL4 EYA2 FGF11 FUT2 GDF5 GPR109A GPX8 H1FX HERC1 HINT3 HOXC11 IGFBP3 JAZF1 KIAA1875 L3MBTL3 LOC440957 LPAL2 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MKX MLXIP MLXIPL MTOR NMRAL1 OTUD4 P4HTM PAM16 PGC POLD3 PPP6R3 PRIM1 PRKAR2A PROCR PSMB3 RAD9A RBL2 RFT1 RP11-108M9.5 RP11-182J1.14 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RP11-95P2.1 RRAS2 RSBN1L RSPO3 RSRC2 SETD8 SLC22A3 SNRPD2 SNUPN SRD5A3 TMEM165 TMEM241 TOM1 TRIM8 UQCC UQCC1 VGLL4 WNT3 WNT4 ZCCHC8 ZSCAN2 |
High blood pressure (mother) |
1.35 |
2 |
1 |
2.2 |
-0.99 |
1.5e-02 |
FLJ12825 LOC100240734 |
Body mass index (BMI) |
1.32 |
28 |
15 |
33.3 |
-0.79 |
2.9e-07 |
ADORA2B AP3B1 C12orf65 C4orf44 C6orf106 CCDC92 DNAH10 GRB14 JAZF1 L3MBTL3 MLXIP MTOR NICN1 NLRC3 ORAOV1 OTUD4 POMC PRDX5 PURA RHOA RP11-380L11.3 RP11-400F19.6 RPS6KA5 RSBN1L RSRC2 SEMA3B-AS1 TCF7L2 ZMAT2 |
Impedance of leg (left) |
2.55 |
73 |
53 |
117.8 |
0.83 |
5.5e-21 |
ADM ADORA2B ALKBH5 AMT AP006621.6 AP3B1 ATP5G2 C10orf11 C6orf106 CD79B CEP250 CTD-3032J10.3 CYBRD1 DNASE1L3 DSCR10 EBPL EDEM2 FANCL FGFR4 FLJ12825 FLJ33630 GDF5 GNL3LP1 HINT3 HOXC6 HSD11B2 IGFBP3 IPPK JAZF1 JUND KCNJ11 KIAA1683 KIAA1875 L3MBTL3 LOC440957 LRRC37A LRRC37A4P MAPT MKX MLXIP MLXIPL MMP16 MTOR MXD3 NLRC3 ORAOV1 OTUD4 PAM PGC PLA2G4B POMC PPP6R3 PRIM1 PURA RAB24 RAD9A RBL2 RBPJ RHOA RNF185 RP11-108M9.5 RP11-182J1.14 RPS6KA5 SEMA3B-AS1 SPSB1 TMEM110 UQCC UQCC1 USP53 WNT4 ZCCHC8 ZFP36L2 ZSCAN2 |
Leg predicted mass (left) |
2.82 |
68 |
57 |
126.7 |
-0.70 |
7.1e-12 |
ADM ADORA2B AKR1C2 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CPEB4 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FLJ33630 GDF5 GPX8 H1FX IGFBP3 IPPK KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAD9A RBL2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Trunk fat mass |
2.09 |
52 |
36 |
80.0 |
-0.54 |
8.4e-06 |
ABHD1 ADAMTS9-AS2 ADORA2B ANAPC10 AP3B1 C12orf65 C6orf106 CASKIN1 CCDC92 CEP250 CLOCK COBLL1 DNAH10 ETAA1 EYA2 GDF5 GRB14 IL12RB1 IQCH JUND KANSL1 KIAA1683 L3MBTL3 LPAL2 LRRC37A2 MAPT MLXIP MTOR OTUD4 PDE4C PRDX5 PURA RAD9A RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RPS6KA5 RRAS2 RSBN1L RSRC2 SLC22A3 SLC26A1 SRD5A3 TBX10 TMEM165 TMEM241 UQCC UQCC1 WNT3 YTHDC2 ZCCHC8 ZSCAN2 |
Waist circumference |
1.60 |
32 |
20 |
44.4 |
0.69 |
4.5e-06 |
ABHD1 AC004540.4 AP3B1 C4orf44 C6orf106 CALCRL CASKIN1 CTBP1 HNRNPA1 HOXC11 HOXC6 IDUA IL12RB1 IQCH JUND KANSL1 KIAA1683 MLXIP OTUD4 PDE4C PPP2R1B RAD9A RP11-400F19.6 RSPO3 SLC26A1 SMTNL1 TBX10 TCEA3 TMEM241 YTHDC2 ZCCHC24 ZNHIT6 |
Past tobacco smoking |
1.11 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A IQCH |
Nervous feelings |
1.27 |
7 |
5 |
11.1 |
0.98 |
6.1e-06 |
CENPW LRRC37A LRRC37A2 LRRC37A4P MAPT SEMA3B-AS1 WNT3 |
Frequency of tenseness / restlessness in last 2 weeks |
1.49 |
8 |
5 |
11.1 |
0.61 |
6.0e-02 |
LRRC37A LRRC37A2 LRRC37A4P MAPT NICN1 NICN1-AS1 RHOA WNT3 |
Hearing difficulty/problems with background noise |
1.26 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CRIP3 LRRC37A4P VGLL4 |
Hair/balding pattern: Pattern 2 |
1.45 |
8 |
4 |
8.9 |
0.60 |
8.6e-02 |
CENPW EPC1 LRRC37A LRRC37A2 LRRC37A4P MAPT SSPN WNT3 |
Had menopause |
1.02 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PRIM1 |
Forced vital capacity (FVC) |
2.38 |
48 |
33 |
73.3 |
-0.47 |
3.8e-04 |
ADCY3 ANAPC10 AP3B1 CCDC53 CD79B CENPW CEP250 CYBRD1 EBPL EEF1G EYA2 FGFR4 FLJ33630 H1FX IGFBP3 IPO8 IQCH L3MBTL3 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MGC57346 MRPS35 NICN1 NLRC3 OTUD4 PPP6R3 PSMB3 RAB24 RAD9A RBL2 RHOA RP11-108M9.5 RP11-182J1.14 RP11-250B2.6 RP1-125I3.2 RP11-64K12.8 RSRC2 SNRPD2 SNUPN UQCC UQCC1 WNT3 WNT4 ZCCHC24 ZSCAN2 |
Heel bone mineral density (BMD) T-score, automated (right) |
2.23 |
17 |
10 |
22.2 |
0.38 |
1.1e-01 |
CCDC92 CTBP1 EBPL KAT5 LACTB2 MMP16 NBEAL2 P4HTM PPP6R3 PROCR RP11-380L11.3 RP11-554A11.9 RSPO3 SLC18B1 WNT4 XKR9 ZNRF3 |
Ever unenthusiastic/disinterested for a whole week |
1.39 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A TIMP4 ZMAT2 |
Qualifications: None of the above |
1.34 |
10 |
7 |
15.6 |
0.48 |
1.4e-01 |
ABCB9 AMT C9orf5 GNL3LP1 NICN1 RBL2 RHOA RSRC2 SETD8 ZCCHC8 |
Heart attack |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A3 |
Allergy |
1.24 |
10 |
4 |
8.9 |
-0.18 |
5.9e-01 |
ABCB9 BANF1 ENDOG FGFR4 IQCH JAZF1 PRR5L RP11-400F19.6 RP11-876N24.5 SETD8 |
Diabetes (self-reported) |
2.20 |
9 |
5 |
11.1 |
0.82 |
6.8e-03 |
CTC-425F1.4 EIF2S2P3 FLJ33630 JAZF1 KCNJ11 RBL2 RP11-400F19.6 TCF7L2 ZCCHC24 |
Hayfever/allergic rhinitis (self-reported) |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-876N24.5 |
Medication: Simvastatin |
1.45 |
4 |
1 |
2.2 |
0.94 |
5.9e-02 |
DMWD FLJ33630 RGS19 VEGFB |
Fluid intelligence score |
1.31 |
6 |
2 |
4.4 |
-0.73 |
6.0e-02 |
ALKBH5 DPY30 KCNJ11 MGAT3 RBL2 SETD8 |
Illnesses of siblings |
1.15 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
C4orf44 RBL2 |
Neuroticism score |
1.52 |
7 |
5 |
11.1 |
0.97 |
3.9e-06 |
ADM LRRC37A LRRC37A2 LRRC37A4P MAPT SEMA3B-AS1 WNT3 |
Weight |
2.26 |
60 |
37 |
82.2 |
-0.66 |
1.4e-09 |
ADORA2B AKR1C2 ANAPC10 AP3B1 C12orf65 C17orf82 C6orf106 CASKIN1 CD79B CENPW CEP250 COBLL1 CYBRD1 DOT1L DSCR10 EBPL EDEM2 FUT2 GDF5 H1FX KANSL1 KCNJ2 L3MBTL3 LPAL2 MGAT3 MLXIP MLXIPL MTOR NICN1 ORAOV1 OTUD4 PGC PPP6R3 PRDX5 PRIM1 PROCR PURA RAB24 RAD9A RBL2 RP11-250B2.5 RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TBX10 TCF7L2 TMEM110 TMEM241 UQCC UQCC1 WNT4 YTHDC2 ZCCHC8 ZNF503-AS2 |
Impedance of arm (right) |
2.12 |
64 |
48 |
106.7 |
0.26 |
3.2e-02 |
ADM AMPD3 AMT C10orf11 C22orf31 C6orf106 CCDC92 CD79B CDC42EP3 CENPW CEP250 CTD-3032J10.3 CYBRD1 DNAH10 EDEM2 EEF1G FGF11 FGFR4 FLJ12825 GNL3LP1 GRB14 HOXC6 IPPK JAZF1 JUND KCNJ11 KIAA1683 L3MBTL3 LOC440957 LRRC37A LRRC37A2 LRRC37A4P MAPT MLXIPL MMP16 MTOR MXD3 NDUFS1 NICN1 P4HTM PLXND1 POMC PPP6R3 PRIM1 PRKAR2A PRR5L RBPJ REEP2 RHOA RP11-108M9.5 RP11-182J1.14 RP1-125I3.2 RP11-380L11.3 RPS6KA5 SEMA3B-AS1 SPSB1 TFG TNFSF12 USP53 WIT1 WNT3 ZNF354C ZNF503-AS2 ZSCAN2 |
Arm fat percentage (right) |
1.76 |
38 |
17 |
37.8 |
-0.51 |
6.3e-04 |
ADM ADORA2B AP3B1 C12orf65 C17orf82 C4orf44 C6orf106 CCDC92 CD79B CENPW COBLL1 DNAH10 ETAA1 FGF11 GRB14 HOXA9 IQCH JUND KIAA1683 MLXIP NICN1 PDE4C PEPD POMC PQLC3 PRDX5 PURA RP11-380L11.3 RP11-400F19.6 RRAS2 RSBN1L RSRC2 SLC26A1 SLC38A11 TCEA3 TCF7L2 TNFSF12 YBX2 |
Trunk fat-free mass |
3.29 |
82 |
67 |
148.9 |
-0.47 |
3.5e-06 |
ABCB9 ADCY3 ADM AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C17orf82 C6orf106 CASKIN1 CCDC53 CCDC92 CD79B CENPW CEP250 CTBP1 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGF11 FGFR4 FLJ33630 FUT2 GDF5 GPX8 H1FX HINT3 IGFBP3 IPPK JAZF1 KANSL1 KIAA1683 L3MBTL3 LOC440957 LPAL2 LUZP1 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NDST1 NUDT6 ORAOV1 OTUD4 PGC POLD3 PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 RBPJ RFT1 RNASEH2B RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSRC2 SETD8 SLC22A3 SNUPN TMEM110 TMEM241 TNFSF12 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Hip circumference |
3.19 |
77 |
56 |
124.4 |
-0.87 |
2.0e-29 |
ABLIM3 ADAMTS9-AS2 ADORA2B ANAPC10 AP006621.6 AP3B1 BCL2L11 C12orf65 C6orf106 CASKIN1 CCDC92 CEBPA CEP250 CEP89 CLOCK COBLL1 CPEB4 CYBRD1 DNAH10 DOT1L EBPL EDEM2 EMILIN2 ETAA1 EYA2 FUT2 GDF5 GRB14 H1FX IPPK KBTBD2 KCNJ2 L3MBTL3 LPAL2 MLXIP MLXIPL MTOR NICN1 ORAOV1 OTUD4 PDCL2 PEPD PGC PITPNC1 PLXND1 PRDX5 PRIM1 PROCR PURA RAD9A RASD1 RBL2 RNF157 RP11-283G6.5 RP11-380L11.3 RP11-95P2.1 RPS6KA5 RRAS2 RSBN1L RSPO3 RSRC2 SETD8 SLC22A3 SLC38A11 SRD5A3 TCF7L2 TMEM165 TMEM241 TOM1 UQCC UQCC1 VEGFB WNT4 YBX2 ZCCHC8 ZMAT2 ZNF503-AS2 |
Alcohol intake versus 10 years previously |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FUT2 |
Father's age at death |
1.14 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NICN1 |
Worrier / anxious feelings |
1.14 |
6 |
3 |
6.7 |
0.97 |
2.3e-04 |
LOC440957 LRRC37A LRRC37A2 LRRC37A4P MAPT SEMA3B-AS1 |
Frequency of tiredness / lethargy in last 2 weeks |
1.32 |
6 |
1 |
2.2 |
-0.69 |
1.3e-01 |
AMT C4orf44 NICN1 NICN1-AS1 P4HTM RHOA |
Hair/balding pattern: Pattern 3 |
2.01 |
7 |
7 |
15.6 |
-0.89 |
6.3e-04 |
CENPW LRRC37A LRRC37A2 LRRC37A4P MAPT SSPN WNT3 |
Number of live births |
1.28 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRRC37A LRRC37A4P WNT4 |
Forced expiratory volume in 1-second (FEV1) |
2.18 |
36 |
26 |
57.8 |
-0.41 |
9.4e-03 |
ADCY3 AMT ANAPC10 AP3B1 CD79B CENPW CEP250 CYBRD1 EBPL EEF1G H1FX IPO8 L3MBTL3 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MGC57346 NICN1 NICN1-AS1 NLRC3 OTUD4 PPP6R3 PRKAR2A RAB24 RAD9A RFT1 RHOA RP11-182J1.14 RP11-250B2.6 RP1-125I3.2 WNT3 WNT4 ZCCHC24 ZSCAN2 |
Pulse rate |
1.62 |
6 |
3 |
6.7 |
0.19 |
7.1e-01 |
ALG10 AMT EEF1G P4HTM PRKAR2A RBL2 |
Qualifications: A levels/AS levels or equivalent |
1.46 |
9 |
3 |
6.7 |
-0.50 |
1.4e-01 |
ABCB9 C12orf65 GNL3LP1 NICN1 NICN1-AS1 RHOA SETD8 UQCC ZCCHC8 |
Mouth/teeth dental problems: Dentures |
1.05 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
HERC1 |
Asthma |
1.24 |
6 |
2 |
4.4 |
-0.58 |
2.3e-01 |
DMWD FGFR4 IQCH PRR5L RP11-400F19.6 RP11-876N24.5 |
Medication: Ibuprofen (e.g. Nurofen) |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A4P |
Medication: Cholesterol lowering |
1.26 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RGS19 |
Forced expiratory volume in 1-second (FEV1), Best measure |
2.15 |
34 |
21 |
46.7 |
-0.41 |
1.0e-02 |
ADCY3 ANAPC10 AP3B1 BCAR3 CD79B CENPW CEP250 EBPL EEF1G EML3 GDF5 H1FX IGFBP3 L3MBTL3 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MGC57346 NICN1 NLRC3 OTUD4 PPP6R3 RAB24 RAD9A RHOA RP11-182J1.14 RP11-250B2.6 RP1-125I3.2 WNT3 WNT4 ZCCHC24 ZSCAN2 |
Pulse wave Arterial Stiffness index |
1.31 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Impedance of arm (left) |
2.15 |
67 |
44 |
97.8 |
0.20 |
9.1e-02 |
ADM AMPD3 AMT C10orf11 C22orf31 C6orf106 CCDC92 CD79B CDC42EP3 CENPW CTD-3032J10.3 CYBRD1 DNAH10 EDEM2 EEF1G FGF11 FGFR4 FLJ12825 GNL3LP1 GRB14 HINT3 HOTAIR HOXC6 IPPK JAZF1 JUND KCNJ11 KIAA1683 L3MBTL3 LOC440957 LRRC37A LRRC37A2 LRRC37A4P MAPT MGC57346 MLXIPL MMP16 MTOR MXD3 NDUFS1 NICN1 NICN1-AS1 P4HTM PLXND1 POMC PPP6R3 PRIM1 PRKAR2A PRR5L RBPJ REEP2 RHOA RP11-108M9.5 RP11-182J1.14 RP11-380L11.3 RPS6KA5 SEMA3B-AS1 SPSB1 SSPN TFG TNFSF12 USP53 WIT1 WNT3 ZNF354C ZNF503-AS2 ZSCAN2 |
Arm fat mass (right) |
1.64 |
40 |
24 |
53.3 |
-0.63 |
5.7e-06 |
ADORA2B AP3B1 C12orf65 C4orf44 C6orf106 CASKIN1 CCDC92 COBLL1 DNAH10 EYA2 GRB14 HOXA9 IQCH JUND KANSL1 L3MBTL3 MLXIP MTOR NICN1 NLRC3 ORAOV1 OTUD4 PEPD PGC POMC PRDX5 PURA RP11-380L11.3 RP11-400F19.6 RPS6KA5 RRAS2 RSBN1L RSRC2 SLC22A3 TCF7L2 TMEM241 UQCC UQCC1 YTHDC2 ZCCHC8 |
Trunk predicted mass |
3.29 |
82 |
67 |
148.9 |
-0.47 |
3.6e-06 |
ABCB9 ADCY3 ADM AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C17orf82 C6orf106 CASKIN1 CCDC53 CCDC92 CD79B CENPW CEP250 CTBP1 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGF11 FGFR4 FLJ33630 FUT2 GDF5 GPX8 H1FX HINT3 IGFBP3 IPPK JAZF1 KANSL1 KIAA1683 L3MBTL3 LOC440957 LPAL2 LUZP1 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NDST1 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 RBPJ RFT1 RNASEH2B RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RP11-548H3.1 RPS6KA5 RRAS2 RSRC2 SETD8 SLC22A3 SNUPN TMEM110 TMEM241 TNFSF12 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Standing height |
3.48 |
110 |
93 |
206.7 |
-0.14 |
1.2e-01 |
ABCB9 ADAM17 ADCY3 ADM AKR1C2 ALKBH5 AMT ANAPC10 AP3B1 ATP6V0A2 C17orf82 C6orf106 CAND2 CASKIN1 CCDC53 CD79B CENPW CEP250 COL15A1 CRIP3 CTBP1 CYBRD1 CYTL1 DISP2 DMWD DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 ELOVL4 FGF11 FGFR4 FUT2 GDF5 GPX8 H1FX HINT3 HSD11B2 IGF1R IGFBP3 JAZF1 KANSL1 KCNJ11 KIAA1875 L3MBTL3 LIPE LOC440957 LPAL2 LRRC37A LRRC37A2 LRRC37A4P LRRC45 LUZP1 MAF1 MAPT MGAT3 MKRN2 MKX MLXIP MRPS35 MTOR NUDT6 OTUD4 P4HTM PGC POLD3 POMC PPP6R3 PRIM1 PRKAR2A PROCR PSMB3 PTPRJ RAB24 RAD9A RBL2 RFT1 RIC8B RNASEH2B RP11-108M9.5 RP11-182J1.14 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RP11-95P2.1 RRAS2 RSBN1L RSRC2 SEMA3B-AS1 SETD8 SLC22A3 SLC25A19 SNUPN SPSB1 SRD5A3 TBX10 TMEM165 TMEM241 TOM1 TRIM8 UQCC UQCC1 WNT3 WNT4 ZCCHC8 ZNF354C ZNHIT6 ZSCAN2 |
Exposure to tobacco smoke at home |
1.02 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C6orf106 |
Tense / 'highly strung' |
1.09 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SEMA3B-AS1 |
Hair/balding pattern: Pattern 4 |
2.93 |
17 |
15 |
33.3 |
-0.60 |
5.2e-03 |
CENPW EPC1 ETAA1 HSD11B2 HSPA4 KANSL1 LRRC37A LRRC37A2 LRRC37A4P MAPT MGC57346 MYEOV SH3PXD2B SSPN VGLL4 WNT3 ZFP36L2 |
Birth weight of first child |
1.57 |
9 |
2 |
4.4 |
-0.61 |
8.2e-02 |
ADAM17 ANAPC10 IGFBP3 IPO8 LPAR1 OTUD4 RASD1 WIT1 WNT4 |
Peak expiratory flow (PEF) |
1.89 |
21 |
14 |
31.1 |
-0.73 |
3.6e-05 |
ANAPC10 ATP6V0A2 CCDC53 CD79B CEP250 CYTL1 GDF5 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT OTUD4 PPP6C PPP6R3 RAD9A TNFAIP8 UQCC UQCC1 WNT3 ZFP36L2 |
Qualifications: O levels/GCSEs or equivalent |
1.32 |
4 |
2 |
4.4 |
-0.46 |
4.3e-01 |
ABCB9 LYG1 NICN1 SETD8 |
Medication: Paracetamol |
1.53 |
6 |
5 |
11.1 |
0.90 |
9.9e-04 |
LRRC37A LRRC37A2 LRRC37A4P MAPT NICN1 WNT3 |
Headache pain in last month |
1.50 |
6 |
5 |
11.1 |
0.96 |
3.9e-05 |
LOC440957 LRRC37A LRRC37A2 LRRC37A4P MAPT WNT3 |
Medication for cholesterol, blood pressure or diabetes |
1.31 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RGS19 |
Gout (self-reported) |
1.50 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
MLXIP MLXIPL |
Hypothyroidism/myxoedema (self-reported) |
1.33 |
8 |
2 |
4.4 |
-0.45 |
2.6e-01 |
ADAM1A CCDC88B HSD11B2 HSD17B1P1 JUND RSBN1L TIMP4 TPCN1 |
Birth weight |
1.55 |
11 |
8 |
17.8 |
-0.33 |
3.3e-01 |
ADAM17 ADAM1A ANAPC10 EIF2S2P3 IGFBP3 L3MBTL3 MLXIPL ORAOV1 RSPO3 WIT1 ZNRF3 |
Forced vital capacity (FVC), Best measure |
2.38 |
47 |
32 |
71.1 |
-0.49 |
2.5e-04 |
ADCY3 ANAPC10 AP3B1 BCAR3 CCDC53 CD79B CENPW CEP250 CYBRD1 EBPL EEF1G EYA2 FLJ33630 GDF5 H1FX IGFBP3 IQCH L3MBTL3 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MGC57346 MRPS35 NICN1 NLRC3 OTUD4 PPP6R3 PSMB3 RAB24 RAD9A RBL2 RP11-108M9.5 RP11-182J1.14 RP11-250B2.6 RP1-125I3.2 RP11-64K12.8 RSRC2 SNRPD2 SNUPN UQCC UQCC1 WNT3 WNT4 ZCCHC24 ZSCAN2 |
Body fat percentage |
2.05 |
47 |
29 |
64.4 |
-0.38 |
4.2e-03 |
ABHD1 ADAMTS9-AS2 ADM AP3B1 C12orf65 C4orf44 C6orf106 CASKIN1 CCDC92 CD79B CENPW CLOCK COBLL1 DNAH10 ETAA1 EYA2 FLJ33630 GRB14 HOXA9 HOXC6 IDUA IL12RB1 IQCH JUND KIAA1683 MAPT MLXIP NICN1 PDCL2 PDE4C PRDX5 PURA RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RSBN1L RSRC2 SLC26A1 SLC38A11 SRD5A3 TCEA3 TCF7L2 TMEM165 TMEM241 TNFSF12 YBX2 ZSCAN2 |
Leg fat percentage (right) |
1.90 |
37 |
26 |
57.8 |
-0.08 |
6.0e-01 |
ADM C12orf65 C4orf44 C6orf106 CALCRL CASKIN1 CCDC92 CD79B CENPW CEP250 COBLL1 DNAH10 FLJ33630 GDF5 GRB14 IL12RB1 IQCH JUND KIAA1683 MLXIP NICN1 PDE4C POMC RP11-380L11.3 RP11-95P2.1 RSBN1L RSRC2 SLC26A1 TCEA3 TCF7L2 TMEM165 TMEM241 UQCC UQCC1 YBX2 ZCCHC24 ZSCAN2 |
Arm fat-free mass (right) |
2.91 |
71 |
56 |
124.4 |
-0.51 |
1.8e-06 |
ADCY3 ADM AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CTBP1 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FUT2 GDF5 GPX8 H1FX HINT3 IGFBP3 IPPK JAZF1 KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 REEP2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 TNFSF12 UQCC UQCC1 ZCCHC8 ZNF503-AS2 |
Comparative body size at age 10 |
1.46 |
18 |
8 |
17.8 |
-0.17 |
4.8e-01 |
ADCY3 AP3B1 C12orf65 C6orf106 CALCRL CRIP3 DOT1L ETAA1 FGFR4 KANSL1 LRRC37A MLXIP ORAOV1 PGC POMC PPP6R3 SEMA3B-AS1 VGLL4 |
Worry too long after embarrassment |
1.11 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A2 LRRC37A4P MAPT |
Wheeze or whistling in the chest in last year |
1.25 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RP11-876N24.5 |
Age at first live birth |
1.30 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
NICN1 ZCCHC8 |
Pulse wave peak to peak time |
1.24 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Qualifications: College or University degree |
1.60 |
26 |
15 |
33.3 |
-0.65 |
8.4e-05 |
ABCB9 AMT C12orf65 C4orf44 C9orf5 EDEM2 EEF1G GNL3LP1 IL12RB1 JUND KIAA1683 LRRC37A LRRC37A2 LRRC37A4P MAPT MGAT3 NDUFS1 NICN1 NICN1-AS1 PDE4C PROCR RBL2 RHOA SETD8 WNT3 ZCCHC8 |
Medication for pain relief, constipation, heartburn |
1.31 |
5 |
2 |
4.4 |
-0.85 |
7.7e-03 |
C6orf106 LRRC37A LRRC37A4P MAPT WNT3 |
Medication: Blood pressure |
1.41 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM1A |
Angina (self-reported) |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A3 |
Medication: Allopurinol |
1.41 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
MLXIP |
Mean time to correctly identify matches |
1.27 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
KANSL1 LRRC37A |
Heart disease (mother) |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A3 |
Whole body fat mass |
1.88 |
49 |
28 |
62.2 |
-0.55 |
1.7e-05 |
ADORA2B ANAPC10 AP3B1 C12orf65 C4orf44 C6orf106 CASKIN1 CCDC92 CEP250 CLOCK COBLL1 DNAH10 ETAA1 EYA2 GDF5 GRB14 IL12RB1 IQCH JUND KANSL1 L3MBTL3 LPAL2 MAPT MLXIP MTOR NICN1 OTUD4 PDE4C PRDX5 PURA RAD9A RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RPS6KA5 RRAS2 RSBN1L RSRC2 SLC22A3 SLC26A1 SRD5A3 TCF7L2 TMEM165 TMEM241 UQCC UQCC1 YTHDC2 ZCCHC8 ZSCAN2 |
Leg fat mass (right) |
1.67 |
35 |
24 |
53.3 |
-0.48 |
1.6e-03 |
AP3B1 C12orf65 C4orf44 C6orf106 CASKIN1 CCDC92 COBLL1 DNAH10 FLJ33630 GRB14 IL12RB1 IQCH JUND L3MBTL3 MLXIP MTOR NICN1 OTUD4 PDE4C POMC PURA RAD9A RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RPS6KA5 RRAS2 RSBN1L RSRC2 SLC22A3 SLC26A1 TCF7L2 TMEM165 TMEM241 ZCCHC8 |
Arm predicted mass (right) |
2.88 |
71 |
57 |
126.7 |
-0.52 |
9.7e-07 |
ADCY3 ADM AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CTBP1 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FUT2 GDF5 GPX8 H1FX IGFBP3 IPPK JAZF1 KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 OTUD4 PGC POLD3 PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 REEP2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 TNFSF12 UQCC UQCC1 ZCCHC8 ZNF503-AS2 |
Pulse rate, automated reading |
1.93 |
31 |
20 |
44.4 |
0.24 |
1.6e-01 |
ALG10 ALKBH5 AMT C4orf44 C6orf106 CALCRL CBY1 CTBP1 EEF1G HERC1 LOC440957 MLXIPL P4HTM PGC PRKAR2A PROCR PTPRJ RBL2 REEP2 RFT1 RHOA RIC8B RP11-182J1.14 RP1-125I3.2 RP11-283G6.5 RP11-95P2.1 RPS6KA5 SEMA3B-AS1 SSPN TKT TMEM110 |
Alcohol intake frequency. |
1.33 |
11 |
7 |
15.6 |
0.79 |
7.2e-04 |
BCAR3 C4orf44 FUT2 LRRC37A LRRC37A2 LRRC37A4P MAPT MLXIPL RP11-400F19.6 SETD8 WNT3 |
Comparative height size at age 10 |
3.35 |
82 |
62 |
137.8 |
-0.19 |
7.3e-02 |
ABCB9 ADAM17 ADCY3 ANAPC10 AP3B1 ATAD2B C10orf11 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CRIP3 CYBRD1 DMWD DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FUT2 GDF5 GPX8 H1FX HINT3 HSD11B2 IL12RB1 JAZF1 JUND KCNJ11 KIAA1875 L3MBTL3 LOC440957 LPAL2 LRRC37A LRRC37A2 LRRC37A4P LRRC45 MAPT MKRN2 MLXIP MTOR OTUD4 PAM PDE4C POMC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 RFT1 RIC8B RNASEH2B RP11-108M9.5 RP11-182J1.14 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RP11-548H3.1 RRAS2 RSRC2 SETD8 SLC22A3 SLC25A19 TMEM241 TRIM8 UQCC UQCC1 WNT3 WNT4 ZCCHC8 ZFP36L2 ZNF354C ZSCAN2 |
Overall health rating |
1.18 |
7 |
2 |
4.4 |
-0.13 |
7.8e-01 |
C6orf106 NICN1 NICN1-AS1 RBL2 RHOA SNRPD2 TMEM241 |
Chest pain or discomfort |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC7A6 |
Age at last live birth |
1.42 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NICN1 |
Medication: Aspirin |
1.29 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A3 |
Knee pain experienced in last month |
1.48 |
5 |
4 |
8.9 |
0.99 |
1.5e-03 |
CEP250 EDEM2 GDF5 UQCC UQCC1 |
Hypertension (Self-reported) |
1.68 |
23 |
12 |
26.7 |
0.51 |
1.2e-02 |
AC004540.4 ADAM1A ADCY3 C22orf31 CALCRL CRIP3 CTD-3032J10.3 FGF11 FGF9 FLJ12825 FUT2 HOXC6 HSPA4 KCNJ11 MXD3 PLA2G4B PTPRJ RBL2 RGS19 THOC5 TNFSF12 VEGFB ZNRF3 |
Illnesses of father: Heart disease |
1.33 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CCDC92 SLC22A3 |
Illnesses of siblings: Diabetes |
1.65 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
EIF2S2P3 TCF7L2 |
Forced expiratory volume in 1-second (FEV1), predicted |
2.25 |
21 |
18 |
40.0 |
-0.17 |
4.5e-01 |
AKR1C2 ANAPC10 C17orf82 CD79B CENPW CEP250 DOT1L DYM GDF5 H1FX JAZF1 L3MBTL3 OTUD4 PGC RAB24 RAD9A RP11-182J1.14 SEMA3B-AS1 TMEM241 UQCC UQCC1 |
Whole body fat-free mass |
3.10 |
77 |
64 |
142.2 |
-0.57 |
1.1e-08 |
ABCB9 ADCY3 ADM ADORA2B AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FLJ33630 FUT2 GDF5 GPX8 H1FX HINT3 IGFBP3 IPPK JAZF1 KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 REEP2 RFT1 RNASEH2B RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 TNFSF12 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Leg fat-free mass (right) |
2.84 |
72 |
58 |
128.9 |
-0.70 |
8.4e-13 |
ABCB9 ADM ADORA2B AKR1C2 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CPEB4 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FLJ33630 FUT2 GDF5 GPX8 H1FX IGFBP3 IPO8 IPPK KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PLA2G4B PPP6R3 PRIM1 PROCR PSMB3 PURA RAD9A RBL2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Arm fat percentage (left) |
1.75 |
33 |
18 |
40.0 |
-0.56 |
4.3e-04 |
ADM ADORA2B AP3B1 C12orf65 C17orf82 C4orf44 C6orf106 CCDC92 CENPW COBLL1 DNAH10 FGF11 GRB14 HOXA9 IQCH JUND MLXIP NICN1 PDE4C POMC PQLC3 PRDX5 PURA RP11-380L11.3 RP11-400F19.6 RRAS2 RSBN1L RSRC2 SLC26A1 TCEA3 TCF7L2 TNFSF12 YBX2 |
Average weekly red wine intake |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SETD8 |
Handedness (chirality/laterality): Left-handed |
1.16 |
4 |
3 |
6.7 |
-0.97 |
2.6e-02 |
LRRC37A2 LRRC37A4P MAPT WNT3 |
Mood swings |
1.53 |
6 |
5 |
11.1 |
0.88 |
1.9e-03 |
LRRC37A LRRC37A2 LRRC37A4P MAPT NICN1 WNT3 |
Diabetes diagnosed by doctor |
2.40 |
11 |
5 |
11.1 |
0.67 |
2.3e-02 |
COBLL1 EIF2S2P3 JAZF1 KCNJ11 PLA2G4B RBL2 RP11-380L11.3 RP11-400F19.6 TCF7L2 ZCCHC24 ZFP36L2 |
Qualifications: nursing, teaching |
1.18 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABCB9 SETD8 |
Mouth/teeth dental problems: Mouth ulcers |
1.59 |
6 |
6 |
13.3 |
0.81 |
7.7e-03 |
IL12RB1 LRRC37A LRRC37A2 LRRC37A4P MAPT WNT3 |
Asthma (self-reported) |
1.23 |
6 |
3 |
6.7 |
-0.12 |
8.2e-01 |
DMWD IQCH PRR5L RP11-400F19.6 RP11-876N24.5 SETD8 |
Osteoporosis (self-reported) |
1.29 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PPP6R3 |
Medication: Gliclazide |
1.64 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCF7L2 |
Smoking status: Current |
1.13 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC53 PPP6C |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
1.77 |
12 |
6 |
13.3 |
-0.62 |
1.4e-02 |
EEF1G EML3 EPC1 LRRC37A LRRC37A2 LRRC37A4P MAPT MGC57346 RP1-125I3.2 UQCC WNT3 WNT4 |
Whole body water mass |
3.08 |
76 |
64 |
142.2 |
-0.59 |
4.7e-09 |
ABCB9 ADCY3 ADM ADORA2B AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CTBP1 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FLJ33630 FUT2 GDF5 GPX8 H1FX HINT3 IGFBP3 IPPK KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 REEP2 RFT1 RNASEH2B RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Leg predicted mass (right) |
2.85 |
71 |
59 |
131.1 |
-0.70 |
1.5e-12 |
ABCB9 ADM ADORA2B AKR1C2 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CPEB4 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FLJ33630 GDF5 GPX8 H1FX IGFBP3 IPO8 IPPK KANSL1 L3MBTL3 LOC440957 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PLA2G4B PPP6R3 PRIM1 PROCR PSMB3 PURA RAD9A RBL2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Arm fat mass (left) |
1.64 |
37 |
23 |
51.1 |
-0.60 |
3.7e-05 |
ADORA2B AP3B1 C12orf65 C4orf44 C6orf106 CASKIN1 CCDC92 COBLL1 DNAH10 EYA2 GRB14 HOXA9 IQCH JUND KANSL1 L3MBTL3 MLXIP MTOR NICN1 ORAOV1 OTUD4 POMC PRDX5 PURA RP11-380L11.3 RP11-400F19.6 RPS6KA5 RRAS2 RSBN1L RSRC2 SLC22A3 TCF7L2 TMEM241 UQCC UQCC1 YTHDC2 ZCCHC8 |
Number of self-reported non-cancer illnesses |
1.29 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
IQCH RGS19 ZNRF3 |
Average weekly champagne plus white wine intake |
1.29 |
3 |
0 |
0.0 |
-1.00 |
6.1e-06 |
LRRC37A LRRC37A4P WNT3 |
Miserableness |
1.36 |
9 |
5 |
11.1 |
0.49 |
1.1e-01 |
AMT LRRC37A LRRC37A2 LRRC37A4P MAPT NICN1 NICN1-AS1 RHOA WNT3 |
Guilty feelings |
1.25 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRRC37A LRRC37A4P MAPT |
Eye problems/disorders: Glaucoma |
1.15 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PTPRJ |
Medication: Blood pressure |
1.85 |
11 |
3 |
6.7 |
0.01 |
9.8e-01 |
CRIP3 CTD-3032J10.3 FGF11 FGF9 HOXC6 KAT5 LRRC37A4P MAPT MYEOV TNFSF12 ZNRF3 |
Supplements: Fish oil (including cod liver oil) |
0.91 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARHGAP26 |
High cholesterol (Self-reported) |
1.57 |
7 |
4 |
8.9 |
0.94 |
4.7e-04 |
ABCA1 C4orf44 FUT2 MKRN2 RGS19 SLC22A3 VEGFB |
Medication: Bendroflumethiazide |
1.28 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FGF11 |
Medication: Paracetamol |
1.47 |
8 |
5 |
11.1 |
0.68 |
2.1e-02 |
LRRC37A LRRC37A2 LRRC37A4P MAPT NICN1 NICN1-AS1 RHOA WNT3 |
Medication: Atorvastatin |
1.35 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A3 |
Basal metabolic rate |
2.88 |
73 |
65 |
144.4 |
-0.63 |
5.5e-10 |
ABCB9 ADM ADORA2B AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CPEB4 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FLJ33630 FUT2 GDF5 GPX8 H1FX IGFBP3 IPPK KANSL1 KCNJ2 L3MBTL3 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RP11-95P2.1 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 UQCC UQCC1 WNT4 ZCCHC8 ZNF503-AS2 |
Leg fat percentage (left) |
1.83 |
35 |
24 |
53.3 |
-0.08 |
6.1e-01 |
ADM C12orf65 C4orf44 C6orf106 CALCRL CASKIN1 CCDC92 CD79B CENPW COBLL1 DNAH10 FLJ33630 GDF5 GRB14 IL12RB1 IQCH JUND KIAA1683 MLXIP NICN1 PDE4C POMC RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RSBN1L RSRC2 SLC26A1 TCEA3 TCF7L2 TMEM165 TMEM241 UQCC UQCC1 ZCCHC24 |
Arm fat-free mass (left) |
2.87 |
68 |
55 |
122.2 |
-0.56 |
2.5e-07 |
ADCY3 ADM AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FUT2 GDF5 GPX8 H1FX IGFBP3 IPPK KANSL1 L3MBTL3 LPAL2 MGAT3 MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 REEP2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 TNFSF12 UQCC UQCC1 ZCCHC8 ZNF503-AS2 |
Irritability |
1.39 |
6 |
6 |
13.3 |
0.97 |
1.4e-05 |
LRRC37A LRRC37A2 LRRC37A4P MAPT MMP16 WNT3 |
Risk taking |
1.08 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SMTNL1 |
Fractured/broken bones in last 5 years |
1.45 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RSPO3 |
Diastolic blood pressure, automated reading |
1.25 |
11 |
5 |
11.1 |
0.49 |
1.1e-01 |
ABCB9 ADAM1A ADM CPEB4 CTD-3032J10.3 KAT5 PLA2G4B SETD8 TMEM241 YBX2 ZCCHC8 |
Vascular/heart problems diagnosed by doctor |
1.60 |
20 |
7 |
15.6 |
-0.48 |
3.1e-02 |
AC004540.4 ADAM1A ADCY3 CLOCK CRIP3 CTD-3032J10.3 E2F3 FGF11 FLJ12825 HOXC6 HSPA4 PIH1D2 PTPRJ RBL2 RGS19 RSRC2 THOC5 TNFSF12 VEGFB ZNRF3 |
Cholesterol lowering medication |
1.88 |
8 |
5 |
11.1 |
0.81 |
8.2e-03 |
ABCA1 DMWD LPAL2 RGS19 RP11-380L11.3 SLC22A3 TCF7L2 VEGFB |
Pain experienced in last month |
1.31 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CENPW NICN1 PPP6C |
Heart attack/myocardial infarction (self-reported) |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A3 |
Heart disease (siblings) |
1.25 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SLC22A3 |
Impedance of whole body |
2.34 |
79 |
61 |
135.6 |
0.54 |
7.5e-08 |
ADM AMPD3 AMT AP006621.6 C10orf11 C6orf106 CCDC92 CD79B CENPW CEP250 CTD-3032J10.3 CYBRD1 EBPL EDEM2 EEF1G FANCL FGFR4 FLJ12825 FLJ33630 GDF5 GNL3LP1 GRB14 HINT3 HOXC6 HSD11B2 IGFBP3 IPPK JAZF1 JUND KCNJ11 KIAA1683 KIAA1875 L3MBTL3 LOC440957 LRRC37A LRRC37A2 LRRC37A4P MAPT MLXIPL MMP16 MTOR MXD3 NICN1 NICN1-AS1 NLRC3 ORAOV1 OTUD4 P4HTM PGC PLA2G4B POMC PPP6R3 PRIM1 PRKAR2A PURA RAB24 RAD9A RBPJ REEP2 RGS19 RHOA RP11-108M9.5 RP11-182J1.14 RP11-380L11.3 RPS6KA5 SEMA3B-AS1 SPSB1 TFG TMEM110 TMEM165 TNFSF12 UQCC UQCC1 USP53 WIT1 WNT3 ZNF354C ZNF503-AS2 ZSCAN2 |
Leg fat mass (left) |
1.64 |
34 |
25 |
55.6 |
-0.48 |
2.1e-03 |
AP3B1 C12orf65 C4orf44 C6orf106 CASKIN1 CCDC92 COBLL1 DNAH10 FLJ33630 GRB14 IL12RB1 IQCH JUND L3MBTL3 MLXIP MTOR NICN1 OTUD4 PDE4C POMC PURA RAD9A RP11-380L11.3 RP11-400F19.6 RP11-95P2.1 RPS6KA5 RSBN1L RSRC2 SLC22A3 SLC26A1 TCF7L2 TMEM165 TMEM241 ZCCHC8 |
Arm predicted mass (left) |
2.86 |
69 |
55 |
122.2 |
-0.55 |
2.0e-07 |
ADCY3 ADM AKR1C2 AMPD3 ANAPC10 AP3B1 C10orf11 C12orf65 C17orf82 C6orf106 CASKIN1 CCDC53 CD79B CENPW CEP250 CYBRD1 DNMT3A DOT1L DSCR10 DYM EBPL EDEM2 FGFR4 FUT2 GDF5 GPX8 H1FX HINT3 IGFBP3 IPPK KANSL1 L3MBTL3 LPAL2 MGAT3 MKX MLXIP MLXIPL MMP16 MTOR MXD3 NUDT6 ORAOV1 OTUD4 PGC PPP6R3 PRIM1 PROCR PSMB3 PURA RAB24 RAD9A RBL2 RFT1 RP11-250B2.5 RP11-250B2.6 RP1-125I3.2 RPS6KA5 RRAS2 RSBN1L RSRC2 SETD8 SLC22A3 TMEM110 TMEM241 TNFSF12 UQCC UQCC1 ZCCHC8 ZNF503-AS2 |